- SEK19.62bn
- SEK43.78bn
- SEK3.55bn
- 56
- 41
- 77
- 60
Annual income statement for Nyfosa AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS/A | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,370 | 2,035 | 2,459 | 3,151 | 3,553 |
Cost of Revenue | |||||
Gross Profit | 905 | 1,415 | 1,650 | 2,091 | 2,444 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 68 | 379 | 50 | 534 | 1,296 |
Operating Profit | 1,302 | 1,656 | 2,409 | 2,617 | 2,257 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,576 | 2,399 | 3,644 | 1,859 | -661 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,382 | 2,225 | 3,112 | 1,693 | -639 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,382 | 2,225 | 3,112 | 1,688 | -638 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,382 | 2,225 | 3,112 | 1,689 | -701 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 8.23 | 12.2 | 16.6 | 8.84 | -3.67 |
Dividends per Share |